The scope of the global Biopharmaceutical Third Party Logistics (3PL) Market was appreciated at US$ 86.37 billion in 2018. The range is projected to touch US$ 120.64 billion by 2025, growing at a CAGR of 4.9% for the duration of the forecast.
Biopharmaceutical third party logistics refers to transportation of medicines from place to another using advanced vehicles. These vehicles are specially designed to automate temperature management and to reduce possibilities of human errors during transportation. Pharmaceutical products are temperature sensitive and require continuous monitoring through tracking devices. Thereby, pharmaceutical companies are using all sort of technologically advanced devices to form effective distribution network.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/biopharmaceutical-third-party-logistics-3pl-market/request-sample
Rising demand for effective logistics system to safely transport temperature sensitive medicines is anticipated to propel biopharmaceutical 3PL market growth. Advent of wide range of biologics and biosimilar which require temperature controlled logistic service for distribution is expected to impel biopharmaceutical third party logistics market growth. Growing adoption of automation in manufacturing facilities to reduce operational costs is driving demand for third party logistic services. In addition, rising demand for biologics owing to growing prevalence of chronic diseases is contributing well to biopharmaceutical third party logistics (3PL) industry growth. Moreover, growing environmental concerns among pharmaceutical companies to reduce carbon footprint will drive the market over the forecast period.
To cater to rising demand for advanced logistic services in biopharmaceutical industry, companies are investing in R&D to develop effective value added services. For instance, in 2018, DHL installed near field communication (NFC) based internet of things (IoT) devices in vehicles to record information using mobile applications. Smart sensor technology measures environmental conditions inside the vehicle and upload this information on mobile application called LifeTrack. Implementation of such technologically advanced devices is supporting DHL in improving their distribution network.
Supply Chain Insights
Based on supply chain, the biopharmaceutical third party logistics market can be bifurcated into non-cold chain and cold chain. Cold chain segment is expected to grow fast over the forecast period owing to rising demand for novel drugs and biologics across the globe. Biologics are temperature sensitive and require additional care during transportation. Logistic service providers use temperature data loggers to measure temperature reading for the product being shipped. These technologically advanced data loggers are capable of measuring humidity, vibration, shock, and temperature. In addition, service providers also use radio frequency identification (RFID) and software to gather information.
Service Type Insights
On the basis of service type, the biopharmaceutical 3PL market can be categorized into transportation, warehousing and storage, and others. Others segment includes procurement services, packaging, and custom and duty management. In 2018, warehousing and storage segment accounted for largest market share. This is attributed to rising demand for third party logistics services among pharmaceutical companies to reduce company’s overheads and operational expenses.
Others segment is likely to expand at lucrative CAGR over the forecast period owing to rising focus on packaging of drugs in terms of uniformity, shelf life, and purity.
Regional Insights
Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. In 2018, North America accounted for largest market share owing to increasing number of pharmaceutical companies in the region. Growing adoption of third party transportation and warehousing services among these companies has contributed well to regional market growth. In addition, increasing number of import and export activities for biopharmaceuticals owing to rising disposable income is driving the market in this region.
Asia Pacific, on the other hand, is anticipated to exhibit highest CAGR over the forecast period. This is attributed to growing number of aging population suffering from diabetes and cardiovascular diseases. Such patients require medicines on regular basis, which is likely to drive demand for effective logistics system among pharmaceutical companies.
Some of the key players in the biopharmaceutical third party logistics market are United Parcel Service of America, Inc; DHL International GmbH.; SF Express; AmerisourceBergen Corporation; and DB Schenker. The market is fragmented owing to presence of large number of companies. This fragmentation is likely to restrict big companies from penetrating into new regions across the globe. Thereby, big market players are adopting advanced technologies from small scale companies to expand their business.
Market Segment:
Biopharmaceutical Third Party Logistics Supply Chain Outlook (Revenue, USD Million, 2014 - 2025)
• Cold Chain
• Non-cold Chain
Biopharmaceutical Third Party Logistics Service Outlook (Revenue, USD Million, 2014 - 2025)
• Transportation
• Air Freight
• Sea Freight
• Overland
• Warehousing and Storage
• Others
Biopharmaceutical Third Party Logistics Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
Browse Full Research Report with TOC @ https://www.millioninsights.com/industry-reports/biopharmaceutical-third-party-logistics-3pl-market
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Primary Research:
1.2.1 List of primary sources include
Chapter 2 Executive Summary
2.1 Market Snapshot, 2018 (USD Million)
Chapter 3 Biopharmaceutical Third Party Logistics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Biopharmaceutical Third Party Logistics Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
Continued…
Get in Touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
The scope of the global Biopharmaceutical Third Party Logistics (3PL) Market was appreciated at US$ 86.37 billion in 2018.
The range is projected to touch US$ 120.64 billion by 2025, growing at a CAGR of 4.9% for the duration of the forecast.
These vehicles are specially designed to automate temperature management and to reduce possibilities of human errors during transportation.
Growing adoption of automation in manufacturing facilities to reduce operational costs is driving demand for third party logistic services.
For instance, in 2018, DHL installed near field communication (NFC) based internet of things (IoT) devices in vehicles to record information using mobile applications.
Supply Chain Insights Based on supply chain, the biopharmaceutical third party logistics market can be bifurcated into non-cold chain and cold chain.
The global Third Party Logistics (3PL) Market is expected to value at USD 1.24 trillion by 2025.
The 3PL industry is subject to witness a substantial growth due to the recent technological advancement in the various logistics services, rising transportation activities in both developed and developing economies across the globe and increasing shipping demand.
The number of service providers are improving their supply chain capabilities due to numerous growth opportunities available, thereby driving market growth, in the recent years.
Globally, the third party logistics industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the 3PL market.
Increasing transportation & infrastructural activates in the Asia Pacific and North America region is anticipated to boost market growth in the upcoming years.
Other application of the third party logistics services include private and local utility sector, healthcare industry, media and entertainment sectors.
